192 related articles for article (PubMed ID: 9731558)
1. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
Bandi JC; García-Pagán JC; Escorsell A; François E; Moitinho E; Rodés J; Bosch J
Hepatology; 1998 Sep; 28(3):677-82. PubMed ID: 9731558
[TBL] [Abstract][Full Text] [Related]
2. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
[TBL] [Abstract][Full Text] [Related]
3. Daily variation in portal blood flow and the effect of propranolol administration in a randomized study of patients with cirrhosis.
Alvarez D; de las Heras M; Abecasis R; Terg R; Gerona S; Albornoz L; Galdame O; Torres J; Mastai R
Hepatology; 1997 Mar; 25(3):548-50. PubMed ID: 9049196
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
5. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
[TBL] [Abstract][Full Text] [Related]
8. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.
Vorobioff JD; Ferretti SE; Zangroniz P; Gamen M; Picabea E; Bessone FO; Reggiardo V; Diez AR; Tanno M; Cuesta C; Tanno HE
Am J Gastroenterol; 2007 Oct; 102(10):2206-13. PubMed ID: 17608776
[TBL] [Abstract][Full Text] [Related]
9. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
[TBL] [Abstract][Full Text] [Related]
10. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.
Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J
Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
Braillon A; Calès P; Lebrec D
Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
[TBL] [Abstract][Full Text] [Related]
12. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
Lotterer E; Wengert A; Fleig WE
Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
Albillos A; Lledó JL; Bañares R; Rossi I; Iborra J; Calleja JL; Garrido A; Escartin P; Bosch J
Hepatology; 1994 Sep; 20(3):611-7. PubMed ID: 7915703
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
16. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in patients with cirrhosis and portal hypertension.
Erice E; Llop E; Berzigotti A; Abraldes JG; Conget I; Seijo S; Reverter E; Albillos A; Bosch J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(12):G1458-65. PubMed ID: 22492691
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of propranolol response by catheterization and Doppler ultrasonography in patients with cirrhosis].
Castaño G; Viudez P; Carlevaro O; Ocampo C; Zandalazini H; Riccitelli M; Sookoian S; Frider B
Acta Gastroenterol Latinoam; 1998; 28(4):291-7. PubMed ID: 10347683
[TBL] [Abstract][Full Text] [Related]
19. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
Schneider AW; Kalk JF; Klein CP
Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis.
Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
Hepatology; 1991 Jan; 13(1):124-8. PubMed ID: 1899080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]